Supplementary Figure S2 from Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figure S2. Schema of CRISPR/Cas9 gene-editing targeting of exon 9 of Calr.
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362538641
